OriGen Clinics
(385) 462-8833 Schedule Consultation
Home
Pain & Mobility Aesthetic & Anti-Aging Sexual Wellness
Regenerative Care & Your Options Innovation in Regenerative Care Your Treatment Guide Patient Experience Visiting OriGen Come for care.
Stay for Utah. Explore places to stay, things to do and more while you're here. Utah Travel Guide →
About Ask Ori Contact Call (385) 462-8833 Schedule Consultation
Innovation in Regenerative Care

Medicine is learning how the body repairs.

Regenerative medicine is an evolving field focused on understanding cells, biological signals, tissues, and the processes involved in repair. As that science develops, it is creating new conversations about how medicine may support the body in ways that were not possible a generation ago.

Innovation does not mean every regenerative treatment is proven, FDA-approved, or appropriate for every patient. Understanding that distinction is part of understanding the science.

A Different Conversation

Beyond symptom management.

Conventional medicine has powerful tools for relieving pain, controlling inflammation, treating disease, repairing injuries, and responding when something goes wrong. Medications, rehabilitation, injections, and surgery can all have an important role in appropriate patient care.

Regenerative medicine adds another area of study: the biology involved in tissue maintenance, cellular communication, inflammation, and repair.

Instead of viewing the body only as a collection of symptoms to control, researchers are studying the mechanisms cells use to communicate, respond to injury, maintain tissue, and influence the surrounding biological environment.

The idea is not to replace good medicine. It is to understand more of the biology medicine can work with.
Inside the Science

What regenerative medicine actually studies.

Regenerative medicine is a broad scientific field. It includes research into cells, signaling mechanisms, biomaterials, tissue engineering, and other biological processes involved in maintaining or repairing tissue.

01
Cellular Biology

Mesenchymal Stromal Cells

MSCs are extensively studied for their biological characteristics, interactions with surrounding tissue, and cell-signaling behavior.
Mesenchymal stromal cells, commonly referred to as MSCs, have become an important subject in regenerative medicine research. Scientists study how these cells behave, how they interact with surrounding biological environments, and how signaling associated with them may influence cellular activity. Research continues across a wide range of potential applications.
02
Communication

Extracellular Vesicles & Exosomes

Tiny extracellular vesicles are being studied for the role they play in communication between cells.
Cells communicate in multiple ways. Extracellular vesicles, including exosomes, can carry proteins, lipids, nucleic acids, and other biological material between cells. Their role in cellular communication has made them a major area of scientific research. This research should not be confused with FDA approval of exosome products for treating disease or medical conditions.
03
Biological Signaling

The Cellular Environment

Cells do not operate independently. Their behavior is influenced by chemical signals, neighboring cells, tissue conditions, and the surrounding environment.
Modern regenerative research increasingly examines the environment surrounding cells. Researchers study signaling molecules, inflammatory pathways, extracellular structures, and cell-to-cell communication to better understand why tissues respond differently to injury, disease, aging, and other biological changes.
04
Clinical Application

Precision & Delivery

Where, how, and why a therapy is administered are part of the clinical decision—not an afterthought.
Advances in imaging, injection techniques, diagnostics, and clinical evaluation can help clinicians make more informed decisions about where a treatment is delivered and whether a particular approach is appropriate. Precision does not guarantee an outcome, but careful evaluation and technique remain important components of responsible medical care.
Why Innovation Matters

Better questions lead to better medicine.

Scientific progress often begins by questioning what we already understand. Regenerative medicine asks increasingly detailed questions about the mechanisms behind tissue health, cellular communication, aging, injury, and recovery.

01

Understand the mechanism.

Researchers continue to investigate what happens at the cellular and molecular level when tissue is injured, stressed, inflamed, or degenerating.

02

Study the biological response.

Understanding how cells communicate and how biological environments change may help researchers identify new therapeutic possibilities.

03

Test what actually works.

A promising mechanism is not the same as a proven clinical treatment. Research, controlled studies, safety evaluation, reproducibility, and regulatory review all matter.

04

Apply science to the individual.

A therapy that is being researched—or that may be appropriate in one context—is not automatically appropriate for every patient, condition, or goal.

The Evolution of the Field

Decades of discovery. An evolving science.

Regenerative medicine did not appear overnight. Its development reflects decades of laboratory research, clinical investigation, technological advances, and an expanding understanding of cellular biology.

1960s

Early evidence of stromal stem-cell populations

Early research helped establish the concept that bone marrow contained cells capable of forming different connective tissues.

Work by researchers including Alexander Friedenstein helped establish foundational observations about colony-forming stromal cells in bone marrow. These early studies contributed to concepts that would later become central to MSC research.
1991

The term “mesenchymal stem cell”

The terminology helped define a rapidly developing area of adult stem-cell research.

Arnold Caplan's work helped popularize the term “mesenchymal stem cell.” Subsequent research greatly expanded the field and also led scientists to debate how these cells should be defined and what mechanisms are responsible for their observed effects.
2000s

Regenerative research expands

Research into stem cells, tissue engineering, biomaterials, signaling, and potential therapeutic applications accelerated.

Researchers increasingly investigated how cellular therapies and tissue-engineering approaches might be used in medicine. Laboratory findings led to broader preclinical research and clinical investigation, while important questions about safety, manufacturing, dosing, and efficacy remained areas of study.
2010s

Signaling becomes a larger part of the story

Research increasingly examined how cells influence surrounding tissue through signaling rather than only through direct replacement of damaged cells.

Scientific interest increasingly focused on paracrine signaling, extracellular vesicles, secreted factors, immune interactions, and the surrounding tissue environment. These developments changed how many researchers thought about the potential mechanisms involved in regenerative biology.
Today

An active field of medicine and research

Regenerative medicine continues to develop across laboratory science, clinical trials, tissue engineering, cell biology, and other areas of biomedical research.

Some regenerative products and applications have established medical uses, while many others remain investigational, unapproved, or supported by varying levels of evidence. That distinction is essential when evaluating any specific therapy.
From Discovery to Care

Innovation requires context.

One of the most important distinctions in regenerative medicine is the difference between an interesting biological mechanism, encouraging research, a therapy being investigated, and a treatment that has established evidence and regulatory approval for a particular use.

01

Discovery

Scientists identify a biological process, cell behavior, signaling mechanism, or therapeutic possibility.

02

Investigation

Researchers examine mechanisms, safety, manufacturing, dosing, and potential applications.

03

Evidence

Clinical research evaluates whether a therapy produces meaningful benefits and what risks or limitations are involved.

04

Clinical Decision

Evidence, regulatory status, individual health, alternatives, risks, and patient goals all inform the conversation.

An Important Distinction

“Regenerative medicine” is not one treatment. It is a broad field containing different technologies, products, research areas, and clinical applications.

The existence of research involving a cell, exosome, biologic, or signaling mechanism does not by itself establish that a particular product is FDA-approved or proven safe and effective for a particular condition.

The OriGen Approach

Innovation without losing perspective.

New science is exciting. Medical decisions still need context. OriGen's approach is to evaluate the individual, discuss the available information, and make treatment decisions through a medical conversation rather than a one-size-fits-all protocol.

Individual Evaluation

Symptoms, health history, goals, previous treatment, and individual circumstances matter when considering any medical option.

Evidence in Context

Emerging research can be promising without being definitive. Patients deserve to understand the difference.

Informed Decisions

Potential benefits, risks, alternatives, uncertainties, and regulatory status should be part of an informed treatment conversation.

Appropriate Care

Regenerative treatment is not appropriate for every person or every condition. Sometimes the appropriate recommendation may be another form of care.

Continued Learning

Medicine changes as evidence develops. Responsible innovation requires remaining engaged with new research without turning every new discovery into a promise.

The Future of Regenerative Medicine

Science moves forward by asking what might be possible.

Regenerative medicine continues to change as researchers learn more about cells, signaling, tissue environments, and the biological systems involved in repair. The opportunity is significant. So is the responsibility to separate possibility from proof. At OriGen, we believe patients deserve both sides of that conversation.

Your Next Step

Ready to find out what may be possible?

You don't need to know which treatment you need. Start with a conversation about what's affecting your life, what you've already tried, and what you'd like to get back to.

Start Here

Talk with the OriGen team about your options.

We'll begin by learning more about your concerns and help determine the appropriate next step.

Schedule a Consultation →
✓ Your consultation is the first step toward understanding which options may be appropriate for you.

Physician-guided regenerative care centered around your goals, your health, and helping you understand what options may be available for moving forward.

Physician-Guided Individualized Care Patient Focused
Regulatory Information

FDA / Laboratory Registration: FDA registration of a source laboratory pertains to facility and manufacturing standards. It does not constitute FDA approval of stem cell products for the diagnosis, treatment, cure, or prevention of any disease.

Utah Required Notice Stem Cell Therapy Disclosure

THIS NOTICE MUST BE PROVIDED TO YOU UNDER UTAH LAW. This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing a stem cell therapy.

Information provided on this website is for general educational purposes and is not intended to replace professional medical advice, diagnosis, or treatment. Treatment recommendations and patient suitability are determined through individual medical evaluation. Individual experiences and results may vary.

© 2026 OriGen Clinics. All rights reserved.
Physician-guided regenerative medicine.